We just covered Growth Stock Portfolio: 12 Stock Picks by Carl C. Icahn and Bausch + Lomb Corporation (NYSE:BLCO) ranks 12th on this list.
Bausch + Lomb Corporation (NYSE:BLCO) has consistently featured in the 13F portfolio of Icahn Capital since the second quarter of 2022. Back then, this position comprised 3.5 million shares. Filings for the fourth quarter of 2025 show that new activity against this holding has been disclosed since then and the fund owns the same number of shares in the company. Bausch operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and internationally. It provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses, and contact lenses that are indicated for therapeutic use and provide optical correction during healing.
READ ALSO: Lone Pine’s Non-AI Strategy Falters: 10 Non-AI Stocks Weighing Down Stephen Mandel’s 2026 Returns.
Bausch + Lomb Corporation (NYSE:BLCO) has historically carried a heavy earnings burden, but CEO Brent Saunders has implemented the Vision 27 initiative. In Q1 2026, the company reported a 59% year-over-year increase in adjusted EBITDA. Investors are also encouraged by a 300 basis point improvement in adjusted SG&A margins, signaling that the company is finally converting its $5 billion+ annual revenue into high-quality earnings. There are headlines around the growth of MIEBO, a treatment for dry eye disease. In late 2025/early 2026, MIEBO prescriptions saw a 110% year-over-year increase. The total dry eye portfolio reached $1.1 billion in 2025 revenue.
While we acknowledge the potential of BLCO as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 10 Best Small-Cap Value Stocks to Buy According to Bares Capital and Billionaire Tom Steyer’s 10 Stock Picks with Huge Upside Potential.
Disclosure: None. Follow Insider Monkey on Google News.
